-
Je něco špatně v tomto záznamu ?
Thermoresponsive β-glucan-based polymers for bimodal immunoradiotherapy - Are they able to promote the immune system?
L. Loukotová, J. Kučka, M. Rabyk, A. Höcherl, K. Venclíková, O. Janoušková, P. Páral, V. Kolářová, T. Heizer, L. Šefc, P. Štěpánek, M. Hrubý,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antibakteriální látky chemická syntéza farmakologie MeSH
- aza sloučeniny chemie MeSH
- beta-glukany chemie MeSH
- brachyterapie metody MeSH
- heterocyklické sloučeniny monocyklické chemie MeSH
- imunitní systém účinky léků MeSH
- komplexní sloučeniny chemie MeSH
- leukocyty účinky léků metabolismus MeSH
- lidé MeSH
- myši inbrední C57BL MeSH
- nádorové buněčné linie MeSH
- oxazoly chemie MeSH
- oxidace-redukce MeSH
- polymery chemie MeSH
- protinádorové látky chemická syntéza farmakologie terapeutické užití MeSH
- radioimunoterapie metody MeSH
- radioizotopy ytria chemie MeSH
- Staphylococcus aureus účinky léků MeSH
- teplota MeSH
- viabilita buněk účinky léků MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A conceptually new bimodal immunoradiotherapy treatment was demonstrated using thermoresponsive polymer β-glucan-graft-poly(2-isopropyl-2-oxazoline-co-2-butyl-2-oxazoline) bearing complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid with yttrium-90(III) at the graft ends. The behavior of this thermoresponsive polymer in aqueous solutions was studied, and it showed the appropriate cloud point temperature for brachytherapy applications. The polymer was tested in vitro, and it exhibited nontoxicity and active uptake into cancer cells and macrophages with colocalization in the lysosomes and macrophagosomes. Moreover, the observed oxidative burst response of the leukocytes established the immunostimulatory properties of the polymer, which were also studied in vivo after injection into the thigh muscles of healthy mice. The subsequent histological evaluation revealed the extensive immune activation reactions at the site of injection. Furthermore, the production of tumor necrosis factor α induced by the prepared polymer was observed in vitro, denoting the optimistic prognosis of the treatment. The biodistribution study in vivo indicated the formation of the polymer depot, which was gradually degraded and excluded from the body. The radiolabeled polymer was used during in vivo antitumor efficiency experiments on mice with EL4 lymphoma. The immunoradiotherapy group (treated with the radiolabeled polymer) demonstrated the complete inhibition of tumor growth during the beginning of the treatment. Moreover, 7 of the 15 mice were completely cured in this group, while the others exhibited significantly prolonged survival time compared to the control group. The in vivo experiments indicated the considerable synergistic effect of using immunoradiotherapy compared to separately using immunotherapy or radiotherapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028722
- 003
- CZ-PrNML
- 005
- 20190823114927.0
- 007
- ta
- 008
- 190813s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jconrel.2017.10.010 $2 doi
- 035 __
- $a (PubMed)29031896
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Loukotová, Lenka $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic.
- 245 10
- $a Thermoresponsive β-glucan-based polymers for bimodal immunoradiotherapy - Are they able to promote the immune system? / $c L. Loukotová, J. Kučka, M. Rabyk, A. Höcherl, K. Venclíková, O. Janoušková, P. Páral, V. Kolářová, T. Heizer, L. Šefc, P. Štěpánek, M. Hrubý,
- 520 9_
- $a A conceptually new bimodal immunoradiotherapy treatment was demonstrated using thermoresponsive polymer β-glucan-graft-poly(2-isopropyl-2-oxazoline-co-2-butyl-2-oxazoline) bearing complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid with yttrium-90(III) at the graft ends. The behavior of this thermoresponsive polymer in aqueous solutions was studied, and it showed the appropriate cloud point temperature for brachytherapy applications. The polymer was tested in vitro, and it exhibited nontoxicity and active uptake into cancer cells and macrophages with colocalization in the lysosomes and macrophagosomes. Moreover, the observed oxidative burst response of the leukocytes established the immunostimulatory properties of the polymer, which were also studied in vivo after injection into the thigh muscles of healthy mice. The subsequent histological evaluation revealed the extensive immune activation reactions at the site of injection. Furthermore, the production of tumor necrosis factor α induced by the prepared polymer was observed in vitro, denoting the optimistic prognosis of the treatment. The biodistribution study in vivo indicated the formation of the polymer depot, which was gradually degraded and excluded from the body. The radiolabeled polymer was used during in vivo antitumor efficiency experiments on mice with EL4 lymphoma. The immunoradiotherapy group (treated with the radiolabeled polymer) demonstrated the complete inhibition of tumor growth during the beginning of the treatment. Moreover, 7 of the 15 mice were completely cured in this group, while the others exhibited significantly prolonged survival time compared to the control group. The in vivo experiments indicated the considerable synergistic effect of using immunoradiotherapy compared to separately using immunotherapy or radiotherapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x chemická syntéza $x farmakologie $7 D000900
- 650 _2
- $a protinádorové látky $x chemická syntéza $x farmakologie $x terapeutické užití $7 D000970
- 650 _2
- $a aza sloučeniny $x chemie $7 D001372
- 650 _2
- $a brachyterapie $x metody $7 D001918
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a komplexní sloučeniny $x chemie $7 D056831
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a heterocyklické sloučeniny monocyklické $x chemie $7 D006573
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunitní systém $x účinky léků $7 D007107
- 650 _2
- $a leukocyty $x účinky léků $x metabolismus $7 D007962
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a oxazoly $x chemie $7 D010080
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a polymery $x chemie $7 D011108
- 650 _2
- $a radioimunoterapie $x metody $7 D016499
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a teplota $7 D013696
- 650 _2
- $a radioizotopy ytria $x chemie $7 D015021
- 650 _2
- $a beta-glukany $x chemie $7 D047071
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kučka, Jan $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic.
- 700 1_
- $a Rabyk, Mariia $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic.
- 700 1_
- $a Höcherl, Anita $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic.
- 700 1_
- $a Venclíková, Kristýna $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic.
- 700 1_
- $a Janoušková, Olga $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic.
- 700 1_
- $a Páral, Petr $u Charles University in Prague, First Faculty of Medicine, Center for Advanced Preclinical Imaging, Salmovska 3, Prague 120 00, Czech Republic; Charles University in Prague, First Faculty of Medicine, Institute of Pathological Physiology, U Nemocnice 5, Prague 128 53, Czech Republic.
- 700 1_
- $a Kolářová, Věra $u Charles University in Prague, First Faculty of Medicine, Center for Advanced Preclinical Imaging, Salmovska 3, Prague 120 00, Czech Republic.
- 700 1_
- $a Heizer, Tomáš $u Charles University in Prague, First Faculty of Medicine, Institute of Pathological Physiology, U Nemocnice 5, Prague 128 53, Czech Republic.
- 700 1_
- $a Šefc, Luděk $u Charles University in Prague, First Faculty of Medicine, Center for Advanced Preclinical Imaging, Salmovska 3, Prague 120 00, Czech Republic.
- 700 1_
- $a Štěpánek, Petr $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic.
- 700 1_
- $a Hrubý, Martin $u Institute of Macromolecular Chemistry AS CR, v. v. i., Heyrovsky sq. 2, Prague 162 06, Czech Republic. Electronic address: mhruby@centrum.cz.
- 773 0_
- $w MED00002621 $t Journal of controlled release : official journal of the Controlled Release Society $x 1873-4995 $g Roč. 268, č. - (2017), s. 78-91
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29031896 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823115141 $b ABA008
- 999 __
- $a ok $b bmc $g 1433871 $s 1067182
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 268 $c - $d 78-91 $e 20171012 $i 1873-4995 $m Journal of controlled release $n J Controlled Release $x MED00002621
- LZP __
- $a Pubmed-20190813
